294 related articles for article (PubMed ID: 11525744)
1. Critical role for glycosphingolipids in Niemann-Pick disease type C.
Zervas M; Somers KL; Thrall MA; Walkley SU
Curr Biol; 2001 Aug; 11(16):1283-7. PubMed ID: 11525744
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.
te Vruchte D; Lloyd-Evans E; Veldman RJ; Neville DC; Dwek RA; Platt FM; van Blitterswijk WJ; Sillence DJ
J Biol Chem; 2004 Jun; 279(25):26167-75. PubMed ID: 15078881
[TBL] [Abstract][Full Text] [Related]
3. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.
Davidson CD; Ali NF; Micsenyi MC; Stephney G; Renault S; Dobrenis K; Ory DS; Vanier MT; Walkley SU
PLoS One; 2009 Sep; 4(9):e6951. PubMed ID: 19750228
[TBL] [Abstract][Full Text] [Related]
4. Consequences of NPC1 and NPC2 loss of function in mammalian neurons.
Walkley SU; Suzuki K
Biochim Biophys Acta; 2004 Oct; 1685(1-3):48-62. PubMed ID: 15465426
[TBL] [Abstract][Full Text] [Related]
5. Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin.
Vance JE; Peake KB
Curr Opin Lipidol; 2011 Jun; 22(3):204-9. PubMed ID: 21412152
[TBL] [Abstract][Full Text] [Related]
6. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.
Sun X; Marks DL; Park WD; Wheatley CL; Puri V; O'Brien JF; Kraft DL; Lundquist PA; Patterson MC; Pagano RE; Snow K
Am J Hum Genet; 2001 Jun; 68(6):1361-72. PubMed ID: 11349231
[TBL] [Abstract][Full Text] [Related]
7. Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice.
Nietupski JB; Pacheco JJ; Chuang WL; Maratea K; Li L; Foley J; Ashe KM; Cooper CG; Aerts JM; Copeland DP; Scheule RK; Cheng SH; Marshall J
Mol Genet Metab; 2012 Apr; 105(4):621-8. PubMed ID: 22366055
[TBL] [Abstract][Full Text] [Related]
8. Lipid and cholesterol trafficking in NPC.
Mukherjee S; Maxfield FR
Biochim Biophys Acta; 2004 Oct; 1685(1-3):28-37. PubMed ID: 15465424
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells.
Karten B; Peake KB; Vance JE
Biochim Biophys Acta; 2009 Jul; 1791(7):659-70. PubMed ID: 19416638
[TBL] [Abstract][Full Text] [Related]
10. Lipid imbalance in the neurological disorder, Niemann-Pick C disease.
Vance JE
FEBS Lett; 2006 Oct; 580(23):5518-24. PubMed ID: 16797010
[TBL] [Abstract][Full Text] [Related]
11. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations.
Zervas M; Dobrenis K; Walkley SU
J Neuropathol Exp Neurol; 2001 Jan; 60(1):49-64. PubMed ID: 11202175
[TBL] [Abstract][Full Text] [Related]
12. Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease.
Marques AR; Gabriel TL; Aten J; van Roomen CP; Ottenhoff R; Claessen N; Alfonso P; Irún P; Giraldo P; Aerts JM; van Eijk M
PLoS One; 2016; 11(1):e0147208. PubMed ID: 26771826
[TBL] [Abstract][Full Text] [Related]
13. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
Boadu E; Nelson RC; Francis GA
Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent.
Gondré-Lewis MC; McGlynn R; Walkley SU
Curr Biol; 2003 Aug; 13(15):1324-9. PubMed ID: 12906793
[TBL] [Abstract][Full Text] [Related]
15. Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease.
Blom TS; Linder MD; Snow K; Pihko H; Hess MW; Jokitalo E; Veckman V; Syvänen AC; Ikonen E
Hum Mol Genet; 2003 Feb; 12(3):257-72. PubMed ID: 12554680
[TBL] [Abstract][Full Text] [Related]
16. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
Maubert A; Hanon C; Metton JP
Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme.
Hashimoto N; Matsumoto I; Takahashi H; Ashikawa H; Nakamura H; Murayama T
Neuropharmacology; 2016 Nov; 110(Pt A):458-469. PubMed ID: 27539961
[TBL] [Abstract][Full Text] [Related]
18. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.
Lloyd-Evans E; Platt FM
Traffic; 2010 Apr; 11(4):419-28. PubMed ID: 20059748
[TBL] [Abstract][Full Text] [Related]
19. N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.
Boudewyn LC; Sikora J; Kuchar L; Ledvinova J; Grishchuk Y; Wang SL; Dobrenis K; Walkley SU
Neurobiol Dis; 2017 Sep; 105():257-270. PubMed ID: 28610891
[TBL] [Abstract][Full Text] [Related]
20. Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport.
Liscum L; Sturley SL
Biochim Biophys Acta; 2004 Oct; 1685(1-3):22-7. PubMed ID: 15465423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
